Status:

UNKNOWN

Effect of LCZ696 on Urinary Microalbumin and Pulse Wave Velocity in Perimenopausal Patients With Hypertension

Lead Sponsor:

LanZhou University

Conditions:

Hypertension

Eligibility:

FEMALE

40-60 years

Phase:

NA

Brief Summary

To explore the efficacy of Sacubitril/Valsartan in the treatment of perimenopausal hypertensive patients, as well as the difference between the antihypertensive efficacy and valsartan, the therapeutic...

Detailed Description

A total of 264 cases of perimenopausal patients with essential hypertension who were admitted to Department of Cardiology, Second Hospital of Lanzhou University,from January, 2020 to March,2021 will b...

Eligibility Criteria

Inclusion

  • Patients with essential hypertension(SBP\>140 and \<180 mmHg, and/or DBP\>90 and \<110 mmHg))were diagnosed according to the hypertension diagnostic criteria of the Chinese Guidelines for Hypertension (2018 Revised Edition);
  • Female aged 45-55 years old and meeting the perimenopausal criteria in the STRAE+10;
  • No other complications, no treatment or ongoing antihypertensive therapy (SBP ≥140mmHg or Diastolic BP ≥90mmHg);
  • Agree to participate in the study and sign the informed consent;

Exclusion

  • Secondary hypertension;
  • History of angioedema;
  • Heart failure NYHA grade III or above (excluding grade III);
  • Liver and kidney dysfunction (ALT or AST≥ three times the upper limit of normal value, that is, ALT≥120U/L,AST≥120U/L, creatinine clearance \< 30ml/min);
  • Hyperkalemia (serum potassium ≥5.5mmol/L);
  • Moderate or above anemia (HGB≤90g/L);
  • Bilateral renal artery stenosis;
  • History of stroke;

Key Trial Info

Start Date :

July 9 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 9 2021

Estimated Enrollment :

264 Patients enrolled

Trial Details

Trial ID

NCT04800081

Start Date

July 9 2020

End Date

July 9 2021

Last Update

March 16 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Cardiology, Second Hospital of Lanzhou University

Lanzhou, GuSu, China